Unit:
Investment Promotion Office, Quanzhou Taiwanese Investment Zone
Project Area:
quanzhou Biomedical Industrial Park of Quanzhou Taiwanese Investment Zone
Industry:
Biological and New Pharmaceutical Industry
Type of Project:
New Project
Cooperation Mode:
Collaborate
Nature of Project:
Encourage
Working Progress in Prior Period:
none
Total Investment:
discussed in detai
Expected to Attract Investment:
discussed in detai
Benefit Analysis:
none
Reason and Condition:
none
Content and Scale:
It mainly introduces enterprises of biomedicine, high-end medical devices, medical services, healthcare and eldercare.
Others:
none
Industry

Biological & New Pharmaceutical Industry

In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.